(Q54392727)

29 May 2018

title

Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms. (English)

1 reference

29 May 2018

8

T Haferlach

1 reference

29 May 2018

3

C Haferlach

1 reference

29 May 2018

1

S Schnittger

1 reference

29 May 2018

author name string

U Bacher

2

1 reference

29 May 2018

T Alpermann

4

1 reference

29 May 2018

F Dicker

5

1 reference

29 May 2018

J Sundermann

6

1 reference

29 May 2018

W Kern

7

1 reference

29 May 2018

publication date

14 January 2011

1 reference

29 May 2018

published in

Leukemia

1 reference

29 May 2018

volume

25

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

615-621

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1038/leu.2010.299

exact match

0 references

cites work

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

21 January 2018

Nucleophosmin and cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Implications of NRAS mutations in AML: a study of 2502 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Cup-like acute myeloid leukemia: new disease or artificial phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

Any role for the nucleophosmin (NPM1) gene in myelodysplastic syndromes and acute myeloid leukemia with chromosome 5 abnormalities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

7 January 2021

Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

7 January 2021

A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

7 January 2021

Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

7 January 2021

Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

7 January 2021

Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

7 January 2021

NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.299

7 January 2021

Identifiers

DOI

10.1038/LEU.2010.299

1 reference

29 May 2018

1 reference

29 May 2018